The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
2.04BCNY
398.98M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
142.27MCNY
17.85M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-23.35%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -1360.66%.Updated Nov 22, 2026
Beta
0.3530x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-30.73%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
2.04BCNY
398.98M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
3.40BCNY
616.56M · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
8.29x
Updated Nov 22, 2026
Price to Sales (TTM)
14.36x
Updated Nov 22, 2026
Price to Book (MRQ)
2.86x
Updated Nov 22, 2026
Enterprise to Revenue
23.92x
Updated Nov 22, 2026
Enterprise to EBITDA
-2.48x
Updated Nov 22, 2026
Gross Margin
-27.14%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -35.54%.Updated Nov 22, 2026
Profit Margin
-23.35%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -1360.66%.Updated Nov 22, 2026
Operating Margin
-975.72%
Updated Nov 22, 2026
Return on Assets (TTM)
-20.89%
Updated Nov 22, 2026
Return on Equity (TTM)
-114.79%
Updated Nov 22, 2026
Revenue (TTM)
142.27MCNY
17.85M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
0.1800CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
253.30%
Updated Nov 22, 2026
Gross Profit (TTM)
-50.56MCNY
-8.23M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
-1.37BCNY
-230.93M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-1.94BCNY
-302.60M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
-75.60%
Updated Nov 22, 2026
Operating Cash Flow (TTM)
53.10MCNY
10.14M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
634.54MCNY
87.93M · vs all stocks (USD)
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.39%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
29.17%
Updated Nov 22, 2026
Minority Interest (Equity)
-2.60MCNYFY2025 · Dec 31, 2025
Revenue
174.54MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
215.30MCNYFY2025 · Dec 31, 2025
Gross Profit
-40.76MCNYFY2025 · Dec 31, 2025
Operating Income
-262.60MCNY
-39.36M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.63BCNYFY2025 · Dec 31, 2025
Income Tax Expense
178.22MCNYFY2025 · Dec 31, 2025
Net Income
-1.81BCNYFY2025 · Dec 31, 2025
EBIT
-1.55BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-262.09MCNYFY2025 · Dec 31, 2025
Research & Development
19.13MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
65.72MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
59.13MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.91MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
80.61MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-2.25CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-2.25CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
795.25MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
795.25MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.81BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
19.71MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-1.47BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.48BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
18.76MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.81BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
87.27MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
51.05MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
196.02MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-10.26MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.64MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-142.47KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-8.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
390.12MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-459.04MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-79.44MCNYFY2025 · Dec 31, 2025
Other Financing Charges
5.65MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-142.70MCNYFY2025 · Dec 31, 2025
Shares Outstanding
794.68MSharesUpdated Nov 22, 2026
Float Shares
741.72MSharesUpdated Nov 22, 2026
% Held by Insiders
21.41%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
0.00%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
180.77MCNY
32.71M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
0.2270CNYUpdated Nov 22, 2026
Total Debt (MRQ)
1.55BCNY
231.84M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
2.18x
Updated Nov 22, 2026
Current Ratio (MRQ)
0.7140x
Updated Nov 22, 2026
Book Value per Share (MRQ)
0.8990CNYUpdated Nov 22, 2026
Total Assets
3.88BCNY
581.71M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.21BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.48BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.67BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
273.91MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.20BCNYFY2025 · Dec 31, 2025
Cash
217.87MCNYFY2025 · Dec 31, 2025
Cash Equivalents
12.84MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
230.71MCNYFY2025 · Dec 31, 2025
Accounts Receivable
842.88MCNYFY2025 · Dec 31, 2025
Inventory
654.47KCNYFY2025 · Dec 31, 2025
Accounts Payable
563.81MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.50BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
22.73MCNYFY2025 · Dec 31, 2025
Long-term Debt
55.00MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
218.14MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
794.68MCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.86BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.40BCNY
210.29M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.55CNYUpdated Nov 22, 2026
52-Week High
4.94CNYUpdated Nov 22, 2026
52-Week Change
-30.73%
vs all stocks
Updated Nov 22, 2026
Beta
0.3530x
vs all stocks
Updated Nov 22, 2026
50-Day MA
3.40CNYUpdated Nov 22, 2026
200-Day MA
3.64CNYUpdated Nov 22, 2026
Avg 10-Day Volume
8.14MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
8.77MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-2.35CNYUpdated Nov 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 23.42Revenue Growth YoY: -0.76
Financial Health
Altman Z-Score -1.3: distress zoneCritical
Altman Z-Score: -1.30
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Revenue is $17.85M, lower than 95% of all stocks globallySignificant